An assessment of zonisamide as an anti-epileptic drug (Q34181957)

31 July 2017

1 reference

title

An assessment of zonisamide as an anti-epileptic drug (English)

1 reference

31 July 2017

Jain KK

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

1

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

1245-1260

1 reference

The antiepileptic drug AWD 131-138 stimulates different recombinant isoforms of the rat GABA(A) receptor through the benzodiazepine binding site

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

The anticonvulsant effects of the enantiomers of losigamone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

3-substituted GABA analogs with central nervous system activity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Remacemide hydrochloride: a novel antiepileptic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

The disposition of valproyl glycinamide and valproyl glycine in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

An assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Clinical pharmacokinetics of new antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Interaction between Ca2+, K+, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

The anticonvulsant zonisamide scavenges free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Biphasic effects of zonisamide on serotonergic system in rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Zonisamide reduces hypoxic-ischemic brain damage in neonatal rats irrespective of its anticonvulsive effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Protective effect of zonisamide, an antiepileptic drug, against transient focal cerebral ischemia with middle cerebral artery occlusion-reperfusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Zonisamide as a neuroprotective agent in an adult gerbil model of global forebrain ischemia: a histological, in vivo microdialysis and behavioral study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Clinical pharmacology and therapeutic drug monitoring of zonisamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Zonisamide in epilepsy: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Pilot study of zonisamide (1,2-benzisoxazole-3-methanesulfonamide) in patients with refractory partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Efficacy and safety of zonisamide: results of a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Treatment of infantile spasms with zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

Heat stroke-like episode in a child caused by zonisamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1245

10.1517/14656566.1.6.1245

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference